September 18, 2014 2:11 AM ET


Company Overview of Progen Pharmaceuticals, Inc.

Key Executives for Progen Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Edward F. Schnipper M.D.28 RelationshipsChief Executive Officer, President and Director65
Thomas D. Kiley Esq.30 RelationshipsCo-Founder and Director71
Paul A. Wender Ph.D.37 RelationshipsCo-Founder, Chief Scientific Advisor and Director--
Richard G. Taylor CPANo RelationshipsVice President of Administration and Finance60
Laurence J. Marton M.D.77 RelationshipsChief Scientific Officer--

Progen Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Edward F. Schnipper M.D. 28 RelationshipsBIND Therapeutics, Inc.65
Thomas D. Kiley Esq. 30 RelationshipsProgen Pharmaceuticals, Inc.71
Paul A. Wender Ph.D. 37 RelationshipsProgen Pharmaceuticals, Inc.--
Michael G. Raab 31 RelationshipsArdelyx, Inc.49
Anthony E. Pegg Ph.D. 8 RelationshipsUniversity of Cambridge--
View All Board Members

Progen Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Progen Pharmaceuticals, Inc. CEO Compensation
Industry Average


Colgate-Palmolive Company Announces Resignation of Nikesh Arora as Director
September 11, 2014 6:07 PM ET
Suominen Corporation Announces Appointments to its Nomination Board
September 02, 2014 6:30 AM ET
Energizer Holdings Inc. Announces Executive Leadership for Household Products and Personal Care Businesses
August 29, 2014 6:15 PM ET
ZIL Limited Announces Resignation of Munaf Ibrahim as Board of Director, Effective from August 25, 2014
August 27, 2014 10:53 AM ET
Rubberex Corp. M Bhd Announces the Changes in Remuneration Committee
August 27, 2014 9:05 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Progen Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at